https://genezen.boldfocus.com/genezen-partners-with-ellys-team-on-development-for-aav-serotype-9-gene-replacement-therapy-for-nedamss-genezen-cto-dr-susan-dcosta-to-join-nonprofits-board/ 2025-05-13T00:04:24+00:00 https://genezen.boldfocus.com/genezen-and-optieum-biotechnologies-partner-to-support-cgmp-manufacturing-of-groundbreaking-car-t-therapy-for-glioblastoma/ 2025-05-05T21:17:03+00:00 https://genezen.boldfocus.com/we-are-proud-to-be-great-place-to-work-certified/ 2025-03-31T19:07:14+00:00 https://genezen.boldfocus.com/wp-content/uploads/2025/03/Amazing_Culture_US.png https://genezen.boldfocus.com/wp-content/uploads/2025/03/Made_To_Feel_Welcome_US.png https://genezen.boldfocus.com/genezen-to-acquire-uniqures-commercial-gene-therapy-manufacturing-operations-in-lexington-ma/ 2024-11-13T10:57:27+00:00 https://genezen.boldfocus.com/genezen-appoints-mike-wourms-as-chief-operations-officer/ 2024-11-13T10:38:40+00:00 https://genezen.boldfocus.com/genezen-announces-strategic-process-development-and-manufacturing-partnership-agreement-with-seattle-childrens-research-institute/ 2024-06-17T15:16:43+00:00 https://genezen.boldfocus.com/genezen-receives-growth-equity-investment-from-ampersand-capital-partners/ 2024-04-08T14:28:44+00:00 https://genezen.boldfocus.com/genezen-strengthens-leadership-with-new-board-appointments/ 2024-04-08T14:27:57+00:00 https://genezen.boldfocus.com/wp-content/uploads/2021/06/D72_2967-768x512-1.png https://genezen.boldfocus.com/wp-content/uploads/2021/06/D72_3259-e1630404265923-768x472-1.png https://genezen.boldfocus.com/wp-content/uploads/2021/06/Tedd-3-1-768x512-1.jpeg https://genezen.boldfocus.com/genezen-breaks-ground-on-cgmp-lentiviral-vector-production-facility/ 2024-04-08T14:27:23+00:00 https://genezen.boldfocus.com/genezen-appoints-vice-president-of-operations/ 2024-04-08T14:17:35+00:00 https://genezen.boldfocus.com/genezen-appoints-vice-president-of-quality-assurance-and-regulatory-affairs/ 2024-04-08T14:17:08+00:00 https://genezen.boldfocus.com/operations-commence-at-genezens-lenti-and-retroviral-vector-process-development-lab/ 2024-04-08T14:16:47+00:00 https://genezen.boldfocus.com/genezens-new-viral-vector-process-development-lab/ 2024-04-08T14:16:20+00:00 https://genezen.boldfocus.com/treadwell-therapeutics-engages-genezen-to-advance-its-t-cell-receptor-based-cell-therapy-pipeline/ 2024-04-08T14:09:42+00:00 https://genezen.boldfocus.com/genezen-announces-launch-of-scientific-advisory-board/ 2024-04-08T14:09:12+00:00 https://genezen.boldfocus.com/genezen-completes-cgmp-lentiviral-and-retroviral-vector-clinical-production-facility-buildout/ 2024-04-08T14:08:36+00:00 https://genezen.boldfocus.com/genezen-monon-bioventures-and-purdue-university-partnership-to-develop-glioblastoma-therapeutic-copy/ 2024-04-08T14:08:03+00:00 https://genezen.boldfocus.com/genezen-delivers-next-phase-cgmp-production-facility-expansion/ 2024-04-08T14:06:01+00:00 https://genezen.boldfocus.com/genezen-announces-the-appointment-of-steven-j-favaloro-as-chief-executive-officer-to-support-next-phase-of-growth/ 2024-04-08T14:05:15+00:00 https://genezen.boldfocus.com/genezen-secures-18-5-million-in-growth-equity-to-expand-viral-vector-development-and-manufacturing-capabilities/ 2024-04-08T14:04:48+00:00 https://genezen.boldfocus.com/genezen-enters-licensing-agreement-with-csl-for-the-cytegrity-stable-lentivirus-production-system-2/ 2024-04-08T14:04:13+00:00